申请人:Grewal Gurmit
公开号:US20090111860A1
公开(公告)日:2009-04-30
The present invention relates to compounds of formula (I) that mediate Edg, including Edg-1, processes for their preparation, pharmaceutical compositions containing them as the active ingredient, to their use as medicaments and to their use in the manufacture of medicaments for use in the treatment in warm-blooded animals such as humans of diseases that have a significant vascularization or inflammatory component such as in tumor-related diseases. The present invention also relates to compounds that inhibit a5bl, and also that exhibit appropriate selectivity profile(s) against other integrins.
本发明涉及公式(I)的化合物,其介导Edg,包括Edg-1,其制备方法,包含它们作为活性成分的制药组合物,它们作为药物的用途以及它们用于制造用于治疗具有显著血管化或炎症成分的疾病的药物,如肿瘤相关疾病。本发明还涉及抑制a5bl的化合物,以及对其他整合素具有适当选择性谱的化合物。